✦ LIBER ✦

Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma

✍ Scribed by Cui Chen, Feng-hua Wang, Xin An, Hui-yan Luo…

Book ID: 120776571
Publisher: Springer
Year: 2012
Tongue: English
Weight: 219 KB
Volume: 71
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-2020-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triplet combination of gemcitabine, pacl

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

✍ Swan Swan Leong; Joseph Wee; Sandeep Rajan; Chee Keong Toh; Wan Teck Lim; Siew W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

A Phase II trial of docetaxel and cispla

A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma

✍ J.S McCarthy; I.F Tannock; P Degendorfer; T Panzarella; M Furlan; L.L Siu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

401 5 fluorouracil (FU) bleomycin (B), e

401 5 fluorouracil (FU) bleomycin (B), epirubicin (E), cisplatin (P) in locally advanced (LA), recurrent and/or metastatic (REC/MTS) undifferentiated carcinoma nasopharyngeal type (UCNT) preliminary activity/toxicity report

✍ A. Fandi; A. Taamma; N. Azli; M. Bachouchi; B. Yanes; E. Cvitkovic; J.P. Armand 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Palliative treatment with low-dose conti

Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type

✍ Abderrahim Fandi; Abdelkrim Taamma; Nacer Azli; Mounir Bachouchi; Bashar Yanes; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## Background: Low-dose protracted continuous infusion (ci) 5-fluorouracil (5-fu), as proposed by lokich et al, has been reported to be active and well tolerated in colorectal and breast cancers. we initiated a phase ii trial with ci 5-fu in heavily pretreated undifferentiated carcinoma of the naso

97 Phase I study of cetuximab (C225)in c

97 Phase I study of cetuximab (C225)in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R&M SCCHN)

✍ J. Bourhis; F. Rivera; R. Mesia; A. Awada; L. Geoffrois; C. Borel; L. Duck; E. B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

864 Combination of gemcitabine and pacli

864 Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy

✍ M. Ikeda; K. Matsumoto; K. Tabata; S. Minamida; T. Fujita; T. Satoh; M. Iwamura; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 16 KB